| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Jaumot Frank E | Director | C/O NUTEX HEALTH INC., 6030 S. RICE AVE. SUITE C, HOUSTON | /s/ Frank E. Jaumot | 09 Feb 2026 | 0001303609 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUTX | Restricted Stock Units (RSUs) | Award | $0 | +603 | $0.000000 | 603 | 14 Jul 2025 | Common Stock | 603 | $0.000000 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. |
| F2 | On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. |